MacRae J D, Lampe H, Banerjee D
Joseph Brant Memorial Hospital, Burlington, Ontario, Canada.
J Otolaryngol. 1991 Oct;20(5):310-4.
Recent papers in the general surgery and otolaryngology literature have shown a positive correlation between blood transfusion and decreased survival in cancer patients. This is felt to be due to immunosuppression (not yet defined) induced by the transfusion. We prospectively analyzed the peripheral blood immune profiles of patients undergoing surgery for control of their squamous cell carcinoma of the upper aerodigestive tract. Pre- and postoperative profiles were examined. T4, T8, natural killer cells, and interleukin 2 receptor-positive T cell subsets were analyzed by flow cytometry. Statistical analysis indicated a significant difference between the non-transfused and transfused subgroups, with the transfused group having a decrease in their T helper cell and interleukin 2 receptor positive helper cell populations. This supports other literature which shows an increased recurrence rate in the transfused patient population. The patients were analyzed comparing blood transfusions, immune status, initial stage of disease, the nodal status of the disease, tumor differentiation, and patient's age yielding transfusion as the greatest single contributing factor to the observed immunological changes.
普通外科和耳鼻喉科文献中最近的论文表明,输血与癌症患者生存率降低之间存在正相关。这被认为是由于输血诱导的免疫抑制(尚未明确)所致。我们前瞻性地分析了接受手术以控制上消化道鳞状细胞癌患者的外周血免疫谱。检查了术前和术后的免疫谱。通过流式细胞术分析T4、T8、自然杀伤细胞和白细胞介素2受体阳性T细胞亚群。统计分析表明,未输血亚组和输血亚组之间存在显著差异,输血组的T辅助细胞和白细胞介素2受体阳性辅助细胞群体减少。这支持了其他文献中显示输血患者群体复发率增加的观点。对患者进行分析,比较输血情况、免疫状态、疾病初始阶段、疾病的淋巴结状态、肿瘤分化以及患者年龄,结果表明输血是观察到的免疫变化的最大单一促成因素。